Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Paridaens · SciRah

Researcher profile · Semantic Scholar

R. Paridaens

Share profile

R. Paridaens — researcher profile on SciRah

h-index: 70
Works: 496
Citations: 27K

Most-cited papers

Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K. Michailidou, P. Hall, A. González-Neira, M. Ghoussaini +215 more
2013Nature Genetics1,146 citations Open access
Semantic Scholar
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
Xiao-Hong R. Yang, J. Chang-Claude, E. Goode, F. Couch +170 more
2011Journal of the National Cancer Institute703 citations Open access
Semantic Scholar
MicroRNA Related Polymorphisms and Breast Cancer Risk
Sofia Khan, Dario Greco, K. Michailidou, R. Milne +157 more
2014PLoS ONE560 citations Open access
Semantic Scholar
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
C. V. D. van de Velde, D. Rea, C. Seynaeve, H. Putter +13 more
2011The Lancet380 citations
Semantic Scholar
Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors
Stefan Nickels, T. Truong, R. Hein, K. Stevens +89 more
2013PLoS Genetics178 citations Open access
Semantic Scholar
Adjuvant trastuzumab in HER2-positive breast cancer.
J. Vanderhaegen, R. Paridaens, P. Neven
2012New England Journal of Medicine152 citations
Semantic Scholar
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
M. Colleoni, A. Giobbie-Hurder, M. Regan, B. Thürlimann +13 more
2011Journal of Clinical Oncology147 citations Open access
Semantic Scholar
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
M. Ewertz, K. Gray, M. Regan, B. Ejlertsen +13 more
2012Journal of Clinical Oncology128 citations Open access
Semantic Scholar
Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice.
E. Yoshihara, A. Smeets, A. Laenen, A. Reynders +7 more
2013Breast123 citations Open access
Semantic Scholar
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
B. Beuselinck, P. Wolter, A. Karadimou, R. Elaidi +11 more
2012British Journal of Cancer111 citations Open access
Semantic Scholar
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency.
S. Hatse, D. Lambrechts, A. Verstuyf, A. Smeets +13 more
2012Carcinogenesis101 citations
Semantic Scholar
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
B. Beuselinck, A. Karadimou, D. Lambrechts, B. Claes +17 more
2013British Journal of Cancer98 citations Open access
Semantic Scholar
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis.
D. Fontein, C. Seynaeve, P. Hadji, E. Hille +13 more
2013Journal of Clinical Oncology78 citations Open access
Semantic Scholar
Prognostic impact of baseline serum C‐reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib
B. Beuselinck, Y. Vano, S. Oudard, P. Wolter +14 more
2014BJU International75 citations
Semantic Scholar
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
Christof Vulsteke, D. Lambrechts, A. Dieudonné, S. Hatse +7 more
2013Annals of Oncology69 citations Open access
Semantic Scholar
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
Christof Vulsteke, A. Pfeil, C. Maggen, M. Schwenkglenks +8 more
2015Breast Cancer Research and Treatment68 citations
Semantic Scholar
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.
Kim Haest, Anujith Kumar, B. van Calster, K. Leunen +15 more
2012Annals of Oncology67 citations Open access
Semantic Scholar
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.
J. Bliss, L. Kilburn, R. Coleman, J. Forbes +13 more
2012Journal of Clinical Oncology63 citations
Semantic Scholar
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative.
O. Brouckaert, R. Paridaens, G. Floris, E. Rakha +2 more
2013Annals of Oncology61 citations Open access
Semantic Scholar
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study
M. Schwenkglenks, R. Pettengell, C. Jackisch, R. Paridaens +4 more
2011Supportive Care in Cancer61 citations Open access
Semantic Scholar
Triple negative breast cancer: clinical characteristics in the different histological subtypes.
G. Dreyer, T. Vandorpe, A. Smeets, K. Forceville +9 more
2013Breast58 citations Open access
Semantic Scholar
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
P. Neven, L. Jongen, A. Lintermans, K. Van Asten +21 more
2018Clinical Cancer Research56 citations Open access
Semantic Scholar
Aromatase inhibitors in the breast cancer clinic: focus on exemestane.
K. Van Asten, P. Neven, A. Lintermans, H. Wildiers +1 more
2014Endocrine-Related Cancer56 citations Open access
Semantic Scholar
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers.
O. Brouckaert, A. Laenen, J. Vanderhaegen, H. Wildiers +13 more
2012Annals of Oncology54 citations Open access
Semantic Scholar
Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
M. Derks, E. J. Blok, C. Seynaeve, J. Nortier +11 more
2017The Lancet Oncology51 citations Open access
Semantic Scholar
VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis
B. Beuselinck, A. Karadimou, D. Lambrechts, B. Claes +21 more
2014Acta oncologica49 citations Open access
Semantic Scholar
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.
W. van de Water, E. Bastiaannet, E. Hille, Elma Meershoek-Klein Kranenbarg +7 more
2012The Oncologist47 citations Open access
Semantic Scholar
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
K. Van Asten, Laurence Slembrouck, S. Olbrecht, L. Jongen +15 more
2018The Oncologist44 citations Open access
Semantic Scholar
Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysis.
B. Beuselinck, E. Lerut, P. Wolter, H. Dumez +8 more
2014Clinical Genitourinary Cancer44 citations
Semantic Scholar
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
A. Lintermans, K. Van Asten, H. Wildiers, A. Laenen +9 more
2014Breast Cancer Research and Treatment41 citations
Semantic Scholar
11q13 is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer
D. Lambrechts, T. Truong, C. Justenhoven, M. Humphreys +147 more
2012Human Mutation40 citations Open access
Semantic Scholar
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
Christof Vulsteke, A. Pfeil, M. Schwenkglenks, R. Pettengell +9 more
2014Breast Cancer Research and Treatment32 citations
Semantic Scholar
Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib
B. Beuselinck, D. Lambrechts, T. van Brussel, P. Wolter +16 more
2014Acta oncologica31 citations Open access
Semantic Scholar
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data.
A. Lintermans, A. Laenen, B. van Calster, M. Van Hoydonck +15 more
2013Annals of Oncology29 citations Open access
Semantic Scholar
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis.
W. van de Water, D. Fontein, J. van Nes, J. Bartlett +11 more
2013European Journal of Cancer29 citations Open access
Semantic Scholar
Long term follow-up of the Intergroup Exemestane Study (IES)
J. Morden, I. Álvarez, Gian Bertelli, A. Coates +17 more
2017Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors
A. Pfeil, Christof Vulsteke, R. Paridaens, A. Dieudonné +7 more
2014BMC Cancer26 citations Open access
Semantic Scholar
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis.
W. van de Water, C. Seynaeve, E. Bastiaannet, C. Markopoulos +10 more
2013The Oncologist26 citations Open access
Semantic Scholar
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials.
I. Noordhoek, E. J. Blok, Elma Meershoek-Klein Kranenbarg, H. Putter +14 more
2020Journal of Clinical Oncology25 citations Open access
Semantic Scholar
Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
M. van Hezewijk, E. Bastiaannet, H. Putter, A. Scholten +10 more
2013Radiotherapy and Oncology25 citations
Semantic Scholar
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies
J. Robertson, A. Di Leo, S. Johnston, S. Chia +5 more
2021npj Breast Cancer24 citations Open access
Semantic Scholar
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
H. Warren, F. Dudbridge, O. Fletcher, N. Orr +136 more
2012Cancer Epidemiology, Biomarkers and Prevention21 citations Open access
Semantic Scholar
The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen.
A. Dieudonné, D. Lambrechts, D. Smeets, A. Belmans +7 more
2014Annals of Oncology20 citations Open access
Semantic Scholar
Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
A. Lintermans, D. Vanderschueren, J. Verhaeghe, K. Van Asten +10 more
2014European Journal of Cancer16 citations
Semantic Scholar
Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor
A. Dieudonné, J. Vandenberghe, I. Geerts, J. Billen +3 more
2011Menopause16 citations
Semantic Scholar
Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer.
J. Robertson, R. Paridaens, J. Lichfield, I. Bradbury +1 more
2021European Journal of Cancer15 citations Open access
Semantic Scholar
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics
V. Diéras, H. Bonnefoi, E. Alba, A. Awada +11 more
2019Breast Cancer Research and Treatment15 citations
Semantic Scholar
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients.
D. Fontein, D. Houtsma, E. Hille, C. Seynaeve +9 more
2012Annals of Oncology13 citations Open access
Semantic Scholar
Symptoms of endocrine treatment and outcome: A retrospective analysis of the monotherapy arms of the BIG 1-98 trial.
J. Huober, B. Cole, J. Wu, A. Giobbie-Hurder +12 more
2011Journal of Clinical Oncology13 citations
Semantic Scholar
Circulating CCL5 Levels in Patients with Breast Cancer: Is There a Correlation with Lymph Node Metastasis?
A. Smeets, B. Brouwers, S. Hatse, A. Laenen +4 more
201312 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Neven×17
Invite
P. Neven — researcher profile on SciRah
H. Wildiers×16
Invite
H. Wildiers — researcher profile on SciRah
D. Lambrechts×15
Invite
D. Lambrechts — researcher profile on SciRah
C. Seynaeve×13
Invite
C. Seynaeve — researcher profile on SciRah

×10

Invite

A. Smeets — researcher profile on SciRah

A. Dieudonné×9

Invite

A. Dieudonné — researcher profile on SciRah

C. V. D. van de Velde×8

Invite

C. V. D. van de Velde — researcher profile on SciRah

Invite

H. Putter — researcher profile on SciRah

Invite

M. Southey — researcher profile on SciRah

M. Christiaens×7

Invite

M. Christiaens — researcher profile on SciRah

P. Schöffski×7

Invite

P. Schöffski — researcher profile on SciRah

Invite

P. Hall — researcher profile on SciRah